ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,257Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 434

$446K Total Retail Price of All Prescriptions

Rank: 56 out of 434

612 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 612 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 612 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 11,389 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 1,023 971 1 2
LISINOPRIL 812 747 2 1
OMEPRAZOLE 646 604 3 5
LEVOTHYROXINE SODIUM 468 433 4 3
HYDROCODONE-ACETAMINOPHEN 438 401 S3 5 4
AMLODIPINE BESYLATE 353 323 6 6
ALENDRONATE SODIUM 350 333 7 15
ZOLPIDEM TARTRATE 297 287 8 11
METOPROLOL TARTRATE 287 269 9 12
ATENOLOL 254 253 10 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 254 249 10 21
WARFARIN SODIUM 246 226 12 18
LOSARTAN POTASSIUM 228 222 13 13
LOVASTATIN 215 207 14 10
METFORMIN HCL 201 194 15 7
TERAZOSIN HCL 188 188 16 40
HYDROCHLOROTHIAZIDE 180 175 17 8
CITALOPRAM HBR 177 135 18 23
SPIRIVA 165 159 19 36
ALLOPURINOL 158 148 20 25
METOPROLOL SUCCINATE 132 131 21 22
GABAPENTIN 126 102 22 14
SERTRALINE HCL 124 99 23 27
FUROSEMIDE 123 114 24 9
NIFEDIPINE ER 122 118 25 86
FINASTERIDE 112 91 26 54
RANITIDINE HCL 102 100 27 31
LOSARTAN-HYDROCHLOROTHIAZIDE 98 98 28 39
POTASSIUM CHLORIDE 95 89 29 20
DONEPEZIL HCL 94 94 30 35
PRAVASTATIN SODIUM 92 91 31 17
BENAZEPRIL HCL 89 77 32 49
CARVEDILOL 82 78 33 24
ATORVASTATIN CALCIUM 81 64 34 19
PLAVIX 78 71 35 64
VENTOLIN HFA 74 69 36 30
GLIMEPIRIDE 74 73 36 58
ISOSORBIDE MONONITRATE ER 72 72 38 68
NAPROXEN 71 67 39 75
LIPITOR 67 65 40 133
OXYCODONE HCL 64 36 S2 41 34
CLOPIDOGREL 62 62 42 41
NIFEDICAL XL 62 52 42 260
AMITRIPTYLINE HCL 62 62 R 42 57
ACTOS 61 61 45 85
MORPHINE SULFATE ER 58 36 S2 46 50
OXYBUTYNIN CHLORIDE 57 45 47 82
GLIPIZIDE ER 57 50 47 65
OXYBUTYNIN CHLORIDE ER 56 54 49 91
TRIAMTERENE-HCTZ 53 53 50 47
CLONIDINE HCL 53 44 50 63
TAMSULOSIN HCL 53 44 50 29
PAROXETINE HCL 52 51 53 61
METFORMIN HCL ER 51 46 54 48
BENICAR HCT 50 37 55 155
GLYBURIDE 50 50 R 55 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 19, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.